The Good Men Project
Become a Premium Member
We have pioneered the largest worldwide conversation about what it means to be a good man in the 21st century.
Your support of our work is inspiring and invaluable.
During Pandemic Peak, Psychiatric Patients Were Rushed Into Institutions
Plastiras would not say how many transferred patients had COVID-19 at the time, nor provide information on patients ages.
As New York State hospitals began to fear the worst last spring that the pace of the coronavirus would overtake their ability to discharge patients and clear beds they had to decide what to do with people being admitted for acute psychiatric care.
A study from Columbia University that looked at a large population of adults iagnosed with schizophrenia has found the youngest group (18-34) had the highest suicide risk and those aged 65 and older had the lowest. In the general US population, younger adults have less risk and older age groups have greater risk.
As New York State hospitals began to fear the worst last spring that the pace of the coronavirus would overtake their ability to discharge patients and clear beds they had to decide what to do with people being admitted for acute psychiatric care.
In the second week of March 2020, only 325 New Yorkers had tested positive for COVID-19 but images from abroad and the pace of infection outlined a worrying forecast. By the end of the week, New York would confirm its first casualty from a virus that has deeply strained the health-care system and claimed more than 51,000 lives statewide.
Cybin” or the “
Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced the formation of its Clinical Advisory Board, with the additions of Maurizio Fava, MD, Psychiatrist-in-Chief in the Department of Psychiatry at Massachusetts General Hospital; Lynn Marie Morski, MD, Esq., President of the Psychedelic Medicine Association; and Anthony Back, MD, Professor in the Department of Medicine and Division of Oncology at the University of Washington. The Clinical Advisory Board will be chaired by Alex Belser, PhD, Cybin’s Chief Clinical Officer.
“We are delighted to welcome three accomplished experts in their respective fields to guide the strategic development of Cybin’s clinical programs. Together, Drs. Fava, Morski, and Back add unparalleled clinical expertise and strengthen our position to advance psychedelic therapeutics. Their insights will be especially valuable as we move our development pipeline through clinical trials,” s
Cybin Establishes Clinical Advisory Board of Renowned Physicians, Dr Maurizio Fava, Dr Lynn Marie Morski and Dr Anthony Back apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.